Dr. Havranek-Kosicek, previously Director of Finance and Control for the DSM Pharma Chemicals business unit of DSM Pharmaceutical Products, the pharmaceutical contract manufacturing and technology organization of Royal DSM has been appointed CFO of the entire business group.

Dr. Havranek-Kosicek will report to Alexander R. Wessels, President and Chief Executive Officer of DSM Pharmaceutical Products.

Prior to joining DSM, Ms. Havranek-Kosicek held executive positions in financial control at Immofinanz, and was Managing Director of AUA Beteiligungen and VicePresident Corporate Subsidiaries and Investor Relations at Austrian Airlines.